home / stock / cocp / cocp news

COCP News and Press, Cocrystal Pharma Inc. From 01/19/21

Stock Information
Company Name: Cocrystal Pharma Inc.
Stock Symbol: COCP
Market: NASDAQ
Website: cocrystalpharma.com
Menu
COCP COCP Quote COCP Short COCP News COCP Articles COCP Message Board
Get COCP Alerts

News, Short Squeeze, Breakout and More Instantly...
COCP - GME, LAC, AMC and COHR among premarket gainers

Tenax Therapeutics, Inc. (TENX) +70% after announcing acquisition of PH Precision Med.Aclaris Therapeutics (ACRS) +66% on positive data from mid-stage rheumatoid arthritis.Minerva Neurosciences (NERV) +42% on announcing sale of Seltorexant Royalty for up to $155M.China Natural ...
COCP - Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement

Program advances within the agreement’s initial two-year timeframe BOTHELL, Wash., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discoveri...

COCP - Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium

BOTHELL, Wash., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication mac...

COCP - Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021

BOTHELL, Wash., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces that management will present...
COCP - Cocrystal sees 2021 cash burn of $800k a month

Cocrystal Pharma ([[COCP]] +1.4%) guides 2021 cash burn $800K/month, according to its presentation.As of 30 September, cash/equivalents stood at $31.8M, with no debt and preferred shares.The company expects cash runway beyond 2022.Source For further details see: Cocrystal sees 2021...

COCP - Cocrystal Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

BOTHELL, Wash., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces management will present at t...

COCP - Nano Dimension (NNDM), Triterras (TRIT), MicroVision (MVIS) and Bridgetown Holdings (BTWN) among premarket gainers

SIFCO Industries (SIF) +54% on Q4 results.Creative Realities (CREX) +21%.Triterras (TRIT) +19%.AIM ImmunoTech (AIM) +17%.Bridgetown Holdings Limited (BTWN) +16%.Lightbridge Corporation (LTBR) +24% after nabbing patent in Eurasia for nuclear fuel assemblies.IZEA Worldwide (IZEA) +15%...
COCP - Cocrystal Pharma to test CDI-45205 against coronaviruses

Cocrystal Pharma ([[COCP]] -9.2%) has selected CDI-45205 as the lead compound for further development against coronaviruses including SARS-CoV-2.CDI-45205 was one of the broad spectrum protease inhibitors that were obtained by an exclusive license from Kansas State University Research Fo...

COCP - Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses

CDI-45205 holds potential as a therapeutic and as a prophylactic to protect against coronavirus transmission, including SARS-CoV-2 BOTHELL, Wash., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company&#...

COCP - CLDR, DOMO, PD and UMC among premarket gainers

China HGS Real Estate (HGSH) +164%.Hexindai (HX) +32%.Sutro Biopharma (STRO) +25% as ovarian cancer drug study offers encouraging interim data.Domo (DOMO) +23% on Q3 results.CIIG Merger (CIIC) +22%.Sigma Labs (SGLB) +20%.Collective Growth Corporation (CGRO) +18%.Foresight Autonomous...
Previous 10 Next 10